News
A new agency member has joined the EPHMRA community!
EPHMRA is pleased to welcome MIMS Medica (Malaysia) Sdn Bhd insight to the EPHMRA community as an Agency member.
Great to have you on board and looking forward to our collaboration.
A big thank you to our Convenors, without you the 2023 Basel Chapter Meeting wouldn’t be possible.
So an individual thankyou to;
Angela Duffy, Senior Director, Research Partnership
Send in your Synopsis for the 2024 Conference 25 - 27 June, London
The Call for Papers is Launched!
Submission deadline is 21 September 2023
The 2023 Conference was a great success and we are now excited to plan our June 2024 event. Can you add your voice by submitting an idea for a paper?
Our next paper at the 2023 Basel Chapter meeting is…
‘ChatGPT in the spotlight: A critical assessment of its value in rare disease research’
‘AI Coding… Coding just became cool’
This paper is being presented at the 2023 Chapter Meeting in Basel by Paolo Gambetti, Head of Innovation and Seb Newton, Associate Director – Purdie Pascoe
Join us at the 2023 Basel chapter meeting for the paper ‘Forecasting: Better assumptions, better calibrations, better data’
The speaker for this session will be Paula Coyle, Director, Blueprint Partnership
Come and join us at the 2023 Basel chapter meeting for the paper...
‘Deploying AI Tools in Social Media monitoring, is AI eradicating the need for the researcher?’
At the 2023 Basel Chapter Meeting…
Mike Pepp, Director, Blueprint Partnership, will present his paper – ‘The AI pandemic: Just how far has AI Spread within Pharma and how quickly do tech experts see it spreading?’.
Carolyn Chamberlain, Global Commercial Director and Ed Corbett, Head of Consulting – Branding Science will be presenting their paper...
‘How improving your AIQ leads to better insights and better strategic decisions’
EPHMRA AI Community - Launch
September 7 2023, 13:30-14:30 UK time
Artificial Intelligence (AI) – it’s a topic rapidly evolving in our industry. EPHMRA is forming a new AI community to come together, to discuss the AI topics EPHMRA should address and the way forward.